Search

New antibiotic candidate Clovibactin eliminates bacteria without developing resistance

Editas and Azzur Group scale up their efforts against sickle cell disease with experimental gene editing medicine EDIT-301

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

Researchers demonstrate that complex data analysis paired with artificial intelligence can predict additional causes of Teratogenicity

Climate change is real – it’s happening now – and it will take an awesome effort from the pharma industry to mitigate it

Nominations are open now – but only until October 10.

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Perrigo’s Opill receives FDA approval following unanimous support from advisory committees

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine